|
17-11-2008
: |
Jubilant augments Clinsys Clinical Research® through acquisition of TrialStat ClinicalAnalytics®, an EDC platform |
|
Jubilant Organosys Ltd. announced today that its subsidiary Clinsys Clinical Research, Inc.®, New Jersey, a global contract research organization (CRO), has acquired TrialStat ClinicalAnalytics® from TrialStat® for a purchase consideration of CAD 750,000.
|
|
29-10-2008
: |
Jubilant Strengthens its Business Model in North America |
|
Jubilant Strengthens its Business Model in North America - strategically Aligns HollisterStier and DRAXIS-Announces New Leadership
|
|
14-10-2008
: |
Jubilant Organosys declares Q2 and H1 FY09 Results |
|
Q2 FY09 Revenues up 52% to Rs. 941 crore
Q2 FY09 EBITDA up 56% to Rs. 184 crore
H1 FY09 Revenues up 53% to Rs. 1,767 crore
H1 FY09 EBITDA up 64% to Rs. 355 crore
|
|
06-10-2008
: |
Jubilant Organosys and Lilly to Form Drug Development Joint Venture. |
|
Indian J.V. expands companies' drug discovery and development collaboration.
|
|
15-07-2008
: |
Jubilant Organosys Reports Q1 FY09 Revenues growth of 53% to Rs. 826.6 crore; Pharma & Life Science revenues increase 72%; Q1 FY09 EBITDA increases 62% to Rs. 173.2 crore. |
|
Revenues for 1st quarter ended June 30, 2008 rose by 53.1% to Rs. 826.6 crore over Q1 FY 2008. The international revenue was also higher by 74% at Rs. 484.6 crore on account of volume growth in the outsourcing related segments comprising CRAMS and DDDS.
|
|
14-07-2008
: |
Jubilant in Drug Discovery partnership with Amgen Inc, USA |
|
Jubilant Biosys Ltd and Amgen Inc, the largest US based Biotech company have announced a drug discovery partnership under which Amgen and Jubilant will collaborate to develop a portfolio of novel drugs in new target areas of interest across multiple therapeutic areas.
|
|
29-05-2008
: |
Jubilant successfully completes acquisition of Draxis for US$ 253 million |
|
Jubilant Organosys Ltd., (Jubilant) an integrated pharmaceutical industry player and India's largest Custom Research and Manufacturing Services (CRAMS) Company announced today that it had completed the transaction effective May 28, 2008, to acquire Canada based Draxis Speciality Pharmaceuticals Inc. (Draxis).
|
|
08-05-2008
: |
Jubilant acquires Speciality Molecules Pvt. Ltd., India |
|
Jubilant Organosys Ltd., has announced that it had acquired Speciality Molecules Pvt. Ltd., a niche manufacturer of Speciality Intermediates with manufacturing facilities located in Ambarnath (near Mumbai) in India.
|
|
22-04-2008
: |
Q4 FY08 Revenues grown 49% to Rs. 6,890 million; Net Profit at Rs. 582 million |
|
FY08 Revenues improved 38% to Rs. 24,889 million; PAT up 76% at Rs. 4,005 million
Board declares increased dividend at 150% for the year
|
|
04-04-2008
: |
Jubilant to acquire Draxis Health |
|
Jubilant Organosys Ltd. and DRAXIS Health Inc. today announced that they have entered into an arrangement agreement whereby a wholly-owned subsidiary of Jubilant Organosys Ltd. will acquire all the outstanding common shares of DRAXIS at a price of US$6.00 per share in cash by way of a plan of arrangement. The total value of this transaction is approximately US$255 million.
|
|
25-02-2008
: |
Jubilant announces US$ 92 million, Custom Research & Manufacturing Services contracts in CY2008 |
|
Jubilant announces new contracts worth US $ 92 million for its Proprietary Products and Exclusive Synthesis segment under CRAMS business for the present calendar year (CY 2008)
|
|
30-01-2008
: |
Jubilant Organosys Reports Q3 and 9M results for FY 2008 |
|
Q3 PAT up 40% at Rs. 894 million; Net Sales grow 37% to Rs. 6,416 million; International Sales up 64%; Q3 CRAMS up 98% at Rs. 3,428 million;
9M PAT up 108% to Rs. 3,423 million; Net sales at Rs. 17,999 million, increase 34%; International sales up 54%; 9M CRAMS up 75% at Rs. 9,064 million
|
|
13-12-2007
: |
Dual Recognition for Jubilant Organosys's Corporate Sustainability Program |
|
Becomes the 'Only Indian Company' to feature in IFC's Report on Companies pioneering Sustainability in global emerging economies. Also receives the CII Award for Commitment to Corporate Sustainability.
|
|
06-12-2007
: |
Jubilant in Drug Discovery partnership with Forest Laboratories, USA |
|
Jubilant Biosys Ltd. and Forest Laboratories Holdings, Ltd have entered into a collaboration agreement to discover small molecule drug candidates for a novel metabolic disorders target.
|
|
16-10-2007
: |
Q2 Net Profit doubles to Rs. 1,100 million; Net Sales up 33% at Rs. 6,183 million |
|
H1 Net Profit up 152% to Rs. 2,529 million; Net Sales up 32% at Rs.11,583 million
|
|
25-09-2007
: |
Jubilant Organosys Ltd. 29th AGM held |
|
Focus on outsourcing services to drive performance
|
|
21-09-2007
: |
Jubilant Organosys Wins Golden Peacock Global Award 2007 for Excellence in Corporate Governance |
|
Award Conferred by World Council for Corporate Governance
|
|
18-09-2007
: |
Jubilant in multi million dollar long term contract with Syngenta |
|
Agreement to strengthen Jubilant's leading position in Custom Research & Manufacturing
|
|
05-09-2007
: |
Jubilant Organosys Rated "A+" by Global Reporting Initiative |
|
First Company in Global Pharmaceuticals sector to achieve this recognition
|
|
14-08-2007
: |
Jubilant Organosys increases Pyridines/Picolines capacity to 42,000 TPA |
|
Strengthens global leadership in CRAMS
|
|
17-07-2007
: |
Q1 Net Profits increase 210% to Rs. 1,429 million; EPS at Rs. 8.02 |
|
Net Sales at Rs. 5,400 million, grow 31%
International sales at Rs. 2,789 million, grow 58%
|
|
01-06-2007
: |
Jubilant Organosys completes acquisition of Hollister-Stier Laboratories |
|
Further strengthen its global CRAMS business given Hollister-Stier's position in the contract injectables segment
|
|
27-04-2007
: |
FY 2007 PAT up 76% Net Sales up 21% |
|
Q4 2007 PAT up 33% Net Sales up 10%
|
|
24-04-2007
: |
Jubilant Organosys Acquires US based Hollister - Stier Laboratories LLC |
|
Largest Overseas Acquisition in Contract Manufacturing (CMO) sector by an
Indian Company
|
|
25-11-2006
: |
Jubilant's state-of-the-art Drug Discovery facility inaugurated in Bangalore |
|
Jubilant's state-of-the-art Drug Discovery facility inaugurated in Bangalore
The largest of its kind in India - providing integrated Drug Discovery solutions
|
|
17-10-2006
: |
Jubilant Organosys Q2 FY2007 Net Sales up 41%,
PAT up 131% on YoY basis |
|
- Jubilant Organosys Q2 FY2007 Net Sales up 41%
- PAT up 131% on YoY basis
- International revenues up 124%, Pharma & Life Science sales up 87%
|
|
18-07-2006
: |
Jubilant Organosys Q1 FY2007 Net Profit up 116% to Rs.461 million |
|
Jubilant Organosys Q1 FY2007 Net Profit up 116% to Rs.461 million
Net Sales up 26% to Rs.4.1 billion; International revenues up 53%
|
|
25-04-2006
: |
Jubilant Organosys prices US$ 200 million FCCB issue |
|
Jubilant Organosys prices US$ 200 million FCCB issue
Proceeds to be used to fund acquisitions and capex
|
|
18-04-2006
: |
Jubilant Organosys Q4 FY2006 Net Sales up 32%, PAT up 41% |
|
FY2006 Net Sales up 29%, PAT up 9%
Board declares 125% dividend for the year
|
|
01-02-2006
: |
Jubilant Organosys Custom Research & Manufacturing |
|
- Order book at US$ 68 million
|
|
14-01-2006
: |
Jubilant Organosys Q3 FY2006 Net Sales up 47% |
|
Net Profit up 36%
International revenues up 55%
Pharma & Life Sciences sales up 68%
Board recommends stock split
|
|
28-10-2005
: |
Jubilant Organosys Q2 FY2006 Net Sales up 17% |
|
-Net Profit declines 11%
-International revenues up 21%, Pharma & Life Science sales up 22%
|
|
05-10-2005
: |
Jubilant acquires Clinical Research Organization in USA |
|
- Jubilant becomes largest Indian CRO
|
|
06-09-2005
: |
Jubilant Organosys allots 990,000 shares to General Atlantic |
|
-Funds raised will support global growth initiatives
|
|
29-08-2005
: |
27th AGM approves Equity placement to General Atlantic, hike in FII limit and stock options for employees |
|
Jubilant to enhance presence in global pharma market
|
|
30-07-2005
: |
Jubilant Organosys to raise Rs. 1.09 billion from General Atlantic |
|
-Equity placed at Rs 1100 per share
|
|
30-07-2005
: |
Jubilant Organosys Releases Q1 FY2006 |
|
-Net Sales up 23%
-International revenues up 32%
|
| 9-10-2007 : |
Clinsys Clinical Research, Inc., announces key hires |
|
Rajagopalan Srinivasan, Ph.D, as Vice Preseident, Global Biostatistics and Christopher Gregory, Ph.D as Scientific Affairs - Director
|
| 9-10-2007 : |
Clinsys Clinical Research, Inc., announces relocation of corporate headquarters
|
|
Relocation of headquarters done to accommodate the company's significant growth and plans for future expansion. The new, larger facility is located in Bedminster, New Jersey
|
| 9-10-2007 : |
Clinsys Clinical Research, Inc., and ITEC Services establish strategic alliance to expand CRO offerings Globally
|
|
The alliance will enable Clinsys to extend its global clinical operations and consulting services in Europe and North Africa
|
|
|
| |
Archives |
|
